Together, the expression of adhesion or BM retention–related markers (CXCL12, DCN, and TGM2) is reduced or lost at advanced stages of multiple myeloma, which could enhance dissemination and reduce retention in the BM microenvironment. This evidence concerns the gene CXCL12 and plasma cell myeloma.